Abstract
A critical appraisal and clinical application of Connolly SJ, Milling TJ, Eikelboom JW, et al. Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med. 2016;375(12):1131-1141. doi: 10.1056/NEJMoa1607887.
DOI
10.22237/crp/1567555500
Recommended Citation
FRIEDLI J. Andexanet alfa is an effective reversal agent for factor Xa inhibitors in patients that develop intracranial hemorrhage. Clin. Res. Prac. 2019 Sep 6;5(2):eP1854. doi: 10.22237/crp/1567555500
Included in
Chemical and Pharmacologic Phenomena Commons, Medical Education Commons, Other Chemicals and Drugs Commons, Pharmaceutical Preparations Commons, Translational Medical Research Commons
